Laura Pat Svetkey, MD

Professor of Medicine
Director of Clinical Research
Vice-chair for Faculty Development & Diversity in the Department of Medicine
Campus mail Duke Box 3487, Durham, NC 27710
Phone (919) 660-6626
Email address svetk001@mc.duke.edu

Laura P. Svetkey, MD MHS is Professor of Medicine, Director of the Duke Hypertension Center, Director of Clinical Research at the Sarah W. Stedman Nutrition and Metabolism Center, Vice Chair for Faculty Development and Diversity in the Department of Medicine. She is also the Director of Duke’s CTSA internal career development award program (KL2).She is a faculty member of the Duke Molecular Physiology Institute (DMPI) and the Cardiovascular Research Center (CVRC). She is co-Director of the Clinical and Translational Core of the Duke O’Brien Center for Kidney Research (DOCK).

Dr. Svetkey has over 30 years of experience in the investigation of hypertension, obesity, and related areas, conducting NIH-sponsored clinical research ranging from behavioral intervention trials to metabolomics and genetics, with a consistent focus on prevention, non-pharmacologic intervention, health disparities and minority health. Her research has affected national guidelines, having served on the 2013 national Hypertension Guideline Panel (JNC) and the Lifestyle Guideline Working Group. She is a member of the Association of American Physicians (AAP).

Dr. Svetkey is Vice Chair for Faculty Development and Diversity in the Department of Medicine.  In this role she implements a wide range of programs to enhance the experience and advancement of faculty and trainees, with particular emphasis on under-represented minorities and women.

Education and Training

  • Fellow in General Internal Medicine, Medicine, Duke University, 1982 - 1983
  • Resident in Medicine, Medicine, Montefiore Medical Center, 1980 - 1982
  • Intern in Medicine, Medicine, Montefiore Medical Center, 1979 - 1980
  • M.D., Harvard University , 1979

Publications

Black, HR, Bourgoignie, JJ, Pickering, T, Svetkey, L, Saddler, MC, Setaro, JF, and Textor, SC. "Report on the working party group for patient selection and preparation." American Journal of Hypertension 4, no. 12 II SUPPL. (1991): 745S-746S.

Scholars@Duke

Svetkey, LP, Helms, MJ, Dunnick, NR, and Klotman, PE. "Clinical characteristics useful in screening for renovascular disease." Southern Medical Journal 83, no. 7 (July 1990): 743-747.

PMID
2371594
Scholars@Duke

Weir, MR, Vlachkis, ND, DeQuattro, V, Douglas, J, Svetkey, LP, Singh, S, Wiedl, SC, Chen, CF, Woodward, DL, and Saunders, E. "Evaluation of the clinical pharmacology of nilvadipine in patients with mild to moderate essential hypertension." Journal of Clinical Pharmacology 30, no. 5 (May 1990): 425-437.

PMID
2189903
Full Text

SVETKEY, LP, DUNHAM, CB, and KLOTMAN, PE. "ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR VERSUS CONVENTIONAL THERAPY IN THE TREATMENT OF HYPERTENSION IN PATIENTS WITH RENAL-INSUFFICIENCY." Clinical Research 38, no. 2 (April 1, 1990): A576-A576.

Scholars@Duke

SMITH, SR, KLOTMAN, PE, and SVETKEY, LP. "ACUTE EFFECT OF ORAL POTASSIUM ON BLOOD-PRESSURE AND RENAL-FUNCTION IN MILD HYPERTENSION." Clinical Research 38, no. 1 (January 1, 1990): A22-A22.

Scholars@Duke

Svetkey, LP, Himmelstein, SI, Dunnick, NR, Wilkinson, RH, Bollinger, RR, McCann, RL, Beytas, EM, and Klotman, PE. "Prospective analysis of strategies for diagnosing renovascular hypertension." Hypertension (Dallas, Tex. : 1979) 14, no. 3 (September 1989): 247-257.

PMID
2670763
Full Text

SVETKEY, LP, and KLOTMAN, PE. "CAPTOPRIL-STIMULATED PLASMA-RENIN AND THE CAPTOPRIL TEST AS SCREENING-TESTS FOR RENOVASCULAR HYPERTENSION." Clinical Research 37, no. 2 (April 1, 1989): A401-A401.

Scholars@Duke

Dunnick, NR, Svetkey, LP, Cohan, RH, Newman, GE, Braun, SD, Himmelstein, SI, Bollinger, RR, McCann, RL, Wilkinson, RH, and Klotman, PE. "Intravenous digital subtraction renal angiography: use in screening for renovascular hypertension." Radiology 171, no. 1 (April 1989): 219-222.

PMID
2648471
Full Text

SVETKEY, LP, and KLOTMAN, PE. "CAPTOPRIL TEST VERSUS CAPTOPRIL-STIMULATED PLASMA-RENIN AS SCREENING-TESTS FOR RENOVASCULAR HYPERTENSION." Kidney International 35, no. 1 (January 1, 1989): 335-335.

Scholars@Duke

Svetkey, LP, Brobyn, R, Deedwania, P, Graham, RM, Morganroth, J, and Klotman, PE. "Double-blind comparison of doxazosin, nadolol, and placebo in patients with mild-to-moderate hypertension." Current Therapeutic Research Clinical and Experimental 43, no. 5 (January 1, 1988): 969-978.

Scholars@Duke

Pages